TACT2 trial – enroll now

Our Center is currently participating in NIH-sponsored Trial to Assess Chelation Therapy 2 (TACT2) study.

This study will provide definitive evidence of the clinical utility or lack thereof of intravenous chelation and oral vitamins and minerals in diabetic patients with coronary disease, defined by a prior myocardial infarction.

We are currently recruiting patients and respectfully request that you consider referring your patients to our site. Eligible patients must be over the age of 50, have a diagnosis of diabetes mellitus (type I or II) and a history of a prior myocardial infarction.

Please feel free to contact me or our site coordinator Tatiana Murcia for more information at 202 8335055 or tmurcia@gwcim.com


Dr. Mikhail Kogan, GWCIM Clinical Director